Evsen, M. S.Sak, M. E.Soydinc, H. E.Guven, S.Basaranoglu, S.Hatipoglu, N. K.Evliyaoglu, O.2024-04-242024-04-2420140390-6663https://hdl.handle.net/11468/21302Objective: The aim of the present study was to evaluate the levels of serum androgens and prostate-specific antigen (PSA) levels in patients with endometriosis. Materials and Methods: Patients with Stage III/IV(advanced stage) endometriosis were compared to controls with respect to basal serum levels of total testosterone (T), free testosterone (fT), androstenedion (A), dehydroepiandrosterone (DHEA), dehydroepiandrosterone-sulphate (DHEA-S), and PSA in the early follicular phase of menstrual cycle for this prospective case control study. Results: Level of T, IT, A, DHEA, and DHEA-S were higher in patients with endometriosis when compared to control subjects, but the difference was not statistically significant. The mean PSA level was 0.0074 +/- 0.0120 ng/ml in patients with endometriosis and 0.0059 +/- 0.0056 ng/ml in control group and there was no statistically significant difference between groups (p = 0.58). Conclusion: Serum basal androgens and PSA levels are higher in endometriosis group with respect to control but the differences are not statistically significant.eninfo:eu-repo/semantics/closedAccessEndometriosisAndrogensProstate-Specific AntigenArticle414432435WOS:0003400813000152-s2.0-8490536881025134292Q4Q4